• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向增强子RNA-SMAD7e的CRISPR-Cas13a抑制膀胱癌发展

CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both and .

作者信息

Che Wenan, Ye Shanting, Cai Aoxiang, Cui Xiaojuan, Sun Yuandong

机构信息

Hunan Key Laboratory of Economic Crops Genetic Improvement and Integrated Utilization, School of Life Sciences, Hunan University of Science and Technology, Xiangtan, China.

Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.

出版信息

Front Mol Biosci. 2020 Nov 17;7:607740. doi: 10.3389/fmolb.2020.607740. eCollection 2020.

DOI:10.3389/fmolb.2020.607740
PMID:33282916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7705062/
Abstract

Enhancers are cis-acting elements that can promote the expression of target genes and respond to estrogen to induce the transcription of eRNAs, which are closely associated with cancer development. Further study on eRNAs may lead to a better understanding of the significance of transcriptional regulation and the progression of malignant tumors. SMAD7 enhancer RNA (SMAD7e) is an estrogen-responsive eRNA. However, the relationship between SMAD7e and bladder cancer remains unclear. SMAD7e was significantly upregulated in bladder cancer tissues and estrogen-stimulated cells. Knockdown of SMAD7e by CRISPR-Cas13a suppressed cell proliferation and migration, and induced cell apoptosis and inhibited cell invasion. Estrogen caused overexpression of SMAD7e and played a facilitating role in bladder cancer cells. Furthermore, knockdown of SMAD7e by CRISPR-Cas13a prevented the cancer-promoting effects of estrogen on bladder cancer both and . The present study suggested the crucial role of SMAD7e in bladder cancer. Estrogen might promote the development of bladder cancer by inducing SMAD7e production. These findings may provide a potential target for CRISPR-mediated gene therapy for bladder cancer in the future.

摘要

增强子是一种顺式作用元件,可促进靶基因的表达并对雌激素作出反应,从而诱导与癌症发展密切相关的eRNA转录。对eRNA的进一步研究可能有助于更好地理解转录调控的意义以及恶性肿瘤的进展。SMAD7增强子RNA(SMAD7e)是一种雌激素反应性eRNA。然而,SMAD7e与膀胱癌之间的关系仍不清楚。SMAD7e在膀胱癌组织和雌激素刺激的细胞中显著上调。通过CRISPR-Cas13a敲低SMAD7e可抑制细胞增殖和迁移,并诱导细胞凋亡和抑制细胞侵袭。雌激素导致SMAD7e过表达,并在膀胱癌细胞中发挥促进作用。此外,通过CRISPR-Cas13a敲低SMAD7e可在体内和体外阻止雌激素对膀胱癌的促癌作用。本研究表明SMAD7e在膀胱癌中起关键作用。雌激素可能通过诱导SMAD7e产生来促进膀胱癌的发展。这些发现可能为未来CRISPR介导的膀胱癌基因治疗提供潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/31e8912324d9/fmolb-07-607740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/af23fb128b33/fmolb-07-607740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/a354ee9869e5/fmolb-07-607740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/7c55cdeb1283/fmolb-07-607740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/35dc5b4e622b/fmolb-07-607740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/31e8912324d9/fmolb-07-607740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/af23fb128b33/fmolb-07-607740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/a354ee9869e5/fmolb-07-607740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/7c55cdeb1283/fmolb-07-607740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/35dc5b4e622b/fmolb-07-607740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b83f/7705062/31e8912324d9/fmolb-07-607740-g005.jpg

相似文献

1
CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both and .靶向增强子RNA-SMAD7e的CRISPR-Cas13a抑制膀胱癌发展
Front Mol Biosci. 2020 Nov 17;7:607740. doi: 10.3389/fmolb.2020.607740. eCollection 2020.
2
Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.雌激素诱导的增强子 RNA-P2RY2e 促进膀胱癌的恶性行为。
Int J Biol Sci. 2018 Jul 27;14(10):1268-1276. doi: 10.7150/ijbs.27151. eCollection 2018.
3
Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1.雌激素通过诱导增强子 RNA-eGREB1 促进膀胱癌的发生。
J Cell Mol Med. 2018 Dec;22(12):5919-5927. doi: 10.1111/jcmm.13861. Epub 2018 Sep 4.
4
A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy.一种多功能脂质型 CRISPR-Cas13a 基因电路传递系统,用于膀胱癌基因治疗。
ACS Synth Biol. 2020 Feb 21;9(2):343-355. doi: 10.1021/acssynbio.9b00349. Epub 2020 Jan 10.
5
A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment.CRISPR-Cas13a 系统用于高效、特异性靶向突变 KRAS 的胰腺癌治疗。
Cancer Lett. 2018 Sep 1;431:171-181. doi: 10.1016/j.canlet.2018.05.042. Epub 2018 Jun 2.
6
Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer.增强子RNA转录对于三阴性乳腺癌中一个新的集落刺激因子1增强子至关重要。
Cancers (Basel). 2022 Apr 6;14(7):1852. doi: 10.3390/cancers14071852.
7
Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.全基因组分析揭示 TDG 在雌激素受体介导的增强子 RNA 转录和 3 维重排中的作用。
Epigenetics Chromatin. 2018 Jan 29;11(1):5. doi: 10.1186/s13072-018-0176-2.
8
Reprogrammed CRISPR-Cas13a targeting the HPV16/18 E6 gene inhibits proliferation and induces apoptosis in E6-transformed keratinocytes.靶向人乳头瘤病毒16/18型E6基因的重编程CRISPR-Cas13a抑制E6转化的角质形成细胞增殖并诱导其凋亡。
Exp Ther Med. 2020 Jun;19(6):3856-3860. doi: 10.3892/etm.2020.8631. Epub 2020 Mar 31.
9
A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.基于 CRISPR Cas13a 的人工光控系统调控长链非编码 RNA MALAT1 的表达并影响膀胱癌细胞的恶性表型。
Int J Biol Sci. 2019 Jun 4;15(8):1630-1636. doi: 10.7150/ijbs.33772. eCollection 2019.
10
Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.单细胞分析表明,增强子-启动子环处的eRNA积累并非维持转录所必需。
Nucleic Acids Res. 2017 Apr 7;45(6):3017-3030. doi: 10.1093/nar/gkw1220.

引用本文的文献

1
Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.癌症中的非编码RNA:结构、功能及临床应用
Cancers (Basel). 2025 Feb 8;17(4):579. doi: 10.3390/cancers17040579.
2
Systemic evaluation of various CRISPR/Cas13 orthologs for knockdown of targeted transcripts in plants.对多种CRISPR/Cas13直系同源物在植物中敲低靶向转录本的系统评估。
Genome Biol. 2024 Dec 5;25(1):307. doi: 10.1186/s13059-024-03448-8.
3
Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy.

本文引用的文献

1
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.通过 CRISPR/Cas13a 系统切割人乳头瘤病毒 E6/E7 mRNA 抑制人宫颈癌细胞的体外和体内生长。
Antiviral Res. 2020 Jun;178:104794. doi: 10.1016/j.antiviral.2020.104794. Epub 2020 Apr 14.
2
A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.基于 CRISPR Cas13a 的人工光控系统调控长链非编码 RNA MALAT1 的表达并影响膀胱癌细胞的恶性表型。
Int J Biol Sci. 2019 Jun 4;15(8):1630-1636. doi: 10.7150/ijbs.33772. eCollection 2019.
3
协同腔内灌注治疗膀胱癌:CRISPR-Cas13a 和芬苯达唑联合治疗。
J Exp Clin Cancer Res. 2024 Aug 12;43(1):223. doi: 10.1186/s13046-024-03146-0.
4
Programmable RNA targeting with CRISPR-Cas13.CRISPR-Cas13 靶向可编程 RNA。
RNA Biol. 2024 Jan;21(1):1-9. doi: 10.1080/15476286.2024.2351657. Epub 2024 May 19.
5
Development of Cas13a-based therapy for cancer treatment.基于 Cas13a 的癌症治疗疗法的开发。
Mol Biol Rep. 2024 Jan 9;51(1):94. doi: 10.1007/s11033-023-09129-2.
6
(Nano)platforms in bladder cancer therapy: Challenges and opportunities.膀胱癌治疗中的(纳米)平台:挑战与机遇
Bioeng Transl Med. 2022 Jun 17;8(1):e10353. doi: 10.1002/btm2.10353. eCollection 2023 Jan.
7
Non-coding RNAs and glioma: Focus on cancer stem cells.非编码RNA与神经胶质瘤:聚焦于癌症干细胞。
Mol Ther Oncolytics. 2022 Sep 17;27:100-123. doi: 10.1016/j.omto.2022.09.005. eCollection 2022 Dec 15.
8
Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research.基于 CRISPR/Cas9 的基因组编辑技术在癌症治疗中的应用:临床前和临床实用性、挑战和未来研究的批判性评价。
Cells. 2022 Sep 6;11(18):2781. doi: 10.3390/cells11182781.
9
The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer.增强子 RNA ADCY10P1 与卵巢癌的进展相关。
J Ovarian Res. 2022 May 14;15(1):61. doi: 10.1186/s13048-022-00987-1.
10
Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades.癌症中的增强子RNA(eRNA):多面手
Cancers (Basel). 2022 Apr 14;14(8):1978. doi: 10.3390/cancers14081978.
A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment.
CRISPR-Cas13a 系统用于高效、特异性靶向突变 KRAS 的胰腺癌治疗。
Cancer Lett. 2018 Sep 1;431:171-181. doi: 10.1016/j.canlet.2018.05.042. Epub 2018 Jun 2.
4
RNA targeting with CRISPR-Cas13.利用CRISPR-Cas13进行RNA靶向
Nature. 2017 Oct 12;550(7675):280-284. doi: 10.1038/nature24049. Epub 2017 Oct 4.
5
Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.ACTRT1 及其增强子 RNA 元件的突变导致遗传性和散发性基底细胞癌中 Hedgehog 信号的异常激活。
Nat Med. 2017 Oct;23(10):1226-1233. doi: 10.1038/nm.4368. Epub 2017 Sep 4.
6
Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.改变的增强子转录是亨廷顿舞蹈病纹状体转录特征的基础。
Sci Rep. 2017 Feb 22;7:42875. doi: 10.1038/srep42875.
7
Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.单细胞分析表明,增强子-启动子环处的eRNA积累并非维持转录所必需。
Nucleic Acids Res. 2017 Apr 7;45(6):3017-3030. doi: 10.1093/nar/gkw1220.
8
Improving Systemic Chemotherapy for Bladder Cancer.改善膀胱癌的全身化疗
Curr Oncol Rep. 2016 May;18(5):27. doi: 10.1007/s11912-016-0512-2.
9
Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases.增强转录增强子的鉴定为疾病提供了机制上的见解。
Trends Genet. 2016 Feb;32(2):76-88. doi: 10.1016/j.tig.2015.11.004. Epub 2016 Jan 15.
10
Coexpression networks identify brain region-specific enhancer RNAs in the human brain.共表达网络鉴定人类大脑中脑区特异增强子 RNA。
Nat Neurosci. 2015 Aug;18(8):1168-74. doi: 10.1038/nn.4063. Epub 2015 Jul 13.